澳洋健康(002172) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was ¥975,222,843.19, representing a 53.75% increase compared to ¥634,283,585.15 in the same period last year[7] - Net profit attributable to shareholders was ¥36,074,414.82, a significant turnaround from a loss of ¥121,844,721.30 in the previous year, marking a 129.61% improvement[7] - Basic earnings per share improved to ¥0.05 from a loss of ¥0.16, indicating a 131.25% increase[7] - Total revenue increased by 54% year-on-year, primarily due to higher prices and sales volume of viscose products[15] - Operating profit for the reporting period was 36,567,001.17, compared to a loss of 133,711,045.78 in the same period last year, driven by increased gross margin from viscose products[15] - Net profit for the reporting period was 36,334,858.20, a significant improvement from a loss of 125,971,123.83 in the previous year[15] Cash Flow - The net cash flow from operating activities reached ¥197,519,222.99, compared to a negative cash flow of ¥262,259,246.41 in the same period last year, reflecting a 175.31% increase[7] - Cash received from sales of goods and services increased by 54% year-on-year, attributed to the rise in market prices and sales volume of viscose products[15] - Cash flow from operating activities decreased by 40% year-on-year, primarily due to a reduction in restricted cash payments[15] - The total cash outflow for operating activities was ¥952,945,396.90, compared to ¥1,298,254,825.76 in the same period last year[50] - The company’s cash flow from operating activities showed a net increase of ¥151,565,493.36 in Q1 2021, compared to ¥186,930,833.47 in the previous year[50] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,081,789,945.26, down 5.37% from ¥6,426,603,320.51 at the end of the previous year[7] - Total liabilities decreased to ¥5,077,152,581.44 from ¥5,458,300,814.89, reflecting a reduction in financial obligations[31] - The company's total equity increased to ¥1,004,637,363.82 from ¥968,302,505.62, showing a positive trend in shareholder value[32] - Short-term borrowings decreased to ¥1,674,020,531.65 from ¥1,823,998,836.02, indicating improved liquidity management[31] - Total current liabilities amounted to ¥4,456,305,734.41, down from ¥4,722,868,460.92, indicating better management of short-term obligations[31] Shareholder Information - The company had a total of 49,262 common shareholders at the end of the reporting period[11] - The largest shareholder, Aoyang Group Co., Ltd., held 30.31% of the shares, amounting to 235,349,599 shares, with 39,800,000 shares pledged[11] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[12] Other Income and Expenses - Non-recurring gains and losses totaled ¥35,705,198.63, primarily from non-current asset disposal gains and government subsidies[8] - Other income increased by 753% year-on-year, mainly due to increased government subsidies related to daily operations[15] - Financial expenses for Q1 2021 were CNY 34,404,521.57, down from CNY 45,536,254.79 in the previous year[38] Investment Activities - The company did not engage in any securities or derivative investments during the reporting period[18][19] - The company reported a significant increase in asset disposal gains of CNY 28,925,531.83 compared to a loss of CNY 84,217.95 in the previous period[39] - The company disposed of fixed assets and other long-term assets, recovering cash of ¥73,888,320.97 in Q1 2021, a significant increase from ¥645,079.14 in the previous year[51] Audit Status - The company has not undergone an audit for the Q1 2021 report, indicating that the figures presented are unaudited[53]